|Bid||8.85 x 1300|
|Ask||10.28 x 800|
|Day's range||9.64 - 10.39|
|52-week range||7.06 - 14.14|
|Beta (5Y monthly)||1.30|
|PE ratio (TTM)||N/A|
|Earnings date||04 Aug 2021 - 09 Aug 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||10.33|
Puma Biotech (PBYI) beats first-quarter estimates for both earnings and sales. Stock up.
Puma Biotech (PBYI) delivered earnings and revenue surprises of 37.93% and 31.03%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Puma Biotechnology released its financial results for the first quarter ended March 31, 2021, after market close on May 6, 2021.